SRCL — Stericycle Cashflow Statement
0.000.00%
Last trade - 00:00- $5.75bn
- $7.13bn
- $2.66bn
- 85
- 41
- 86
- 81
Annual cashflow statement for Stericycle, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -346 | -55.9 | -26.8 | 56.5 | -21.3 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 406 | 173 | 37.2 | 22.7 | 107 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -50.4 | 148 | 39.1 | -132 | -56.6 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 248 | 530 | 303 | 200 | 243 |
| Capital Expenditures | -194 | -120 | -117 | -132 | -131 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 90.2 | 501 | 26.8 | 47.6 | 87.5 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -104 | 381 | -90.1 | -84.6 | -43.8 |
| Financing Cash Flow Items | -9.5 | -8.7 | -4.8 | -0.7 | -1.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -142 | -893 | -208 | -111 | -220 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.4 | 18.6 | 2.3 | 0.4 | -20.7 |